Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT01852292 |
Title | Study of Efficacy and Safety of Buparlisib (BKM120) Plus Paclitaxel Versus Placebo Plus Paclitaxel in Recurrent or Metastatic Head and Neck Cancer Previously Pre-treated With a Platinum Therapy |
Recruitment | Terminated |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Novartis Pharmaceuticals |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA | POL | ITA | IRL | HUN | GBR | FRA | ESP | DEU | CHE | CAN | AUS |